Comprehensive characterization of pathogenic missense CTRP6 variants and their association with cancer
Our screening and predictive analysis of pathogenic missense variants in CTRP6 advance the understanding of the functional implications of these mutations, potentially facilitating more focused and efficient research in the future.
Authors
- Arslan Hamid (ORCID: https://orcid.org/0000-0002-2861-013X)
- Jyotsna Kumar
- Muhammad Zubair Mehboob (ORCID: https://orcid.org/0000-0002-5659-5192)
- Xia Lei (ORCID: https://orcid.org/0000-0003-4241-6576)
Institutions
- Oklahoma State University (US)
- University of Bonn (DE)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1186/s12885-025-13685-0
- Citations
- 1
- Primary Topic
- PARP inhibition in cancer therapy
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Oklahoma State University
- Higher Education Commision, Pakistan
- National Institutes of Health